Skip to content

Uvea

Active
Private limited companyfounded 20206 yrs activeDenneboomweg(VSN) 1, 3300 Tienen, BelgiumKBO/BCE: BE 0751.577.675
Summary

Uvea has been active since 2020 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €97,764 and a net result of €56,399. Equity is growing by ~13.3% per year across the filed fiscal years. Its solvency ranks better than 81% of 16718 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Checked score

Score 2025
Axes · tick = 2024
Profitability100=
Solvency100=
Growth78=
Track record100
Bankruptcy probability, 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €9,000 at 30 days acceptable
Liquidity ample (current ratio 8.72 against 4.88 in 2024; short-term debt: 11.3% and cash: 98.2% of total assets), and 11.3% of the assets are financed with debt.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 6 years 0 10 y
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
88.7%
Return on assets
51.2%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 21-05-2026, 71 days ahead of the deadline.
NBB · 5 filings
Deviation from the deadline
2025
71 d early
2024
70 d early
2023
37 d early
2022
97 d early
2021
32 d early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 5 accounts on average 61 days before the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
27-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

On 29 July 2020, Uvea was incorporated as a Private limited company.1 Total assets went from EUR 105,956 in 2021 to EUR 110,165 in 2025.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2021 and 2025

Go further with this company

Is this your company? See how customers and banks see it.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2025, micro schema

Equity
€97,764▲ 12.0%
2024 · €87,255
Total assets
€110,165▲ 2.5%
2024 · €107,503
Net result
€56,399▲ 22.9%
2024 · €45,891
Working capital
€95,727▲ 27.1%
2024 · €75,338
Trend over the years

Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings. Dashed line: the median.

Every figure with its change against the fiscal year before
favourable unfavourable
Line20212022202320242025
Operating result€53,497-€64,754▲ 21.0%€55,146▼ 14.8%€58,069▲ 5.3%€71,308▲ 22.8%
Net result€38,364within the sector's middle half-€51,133within the sector's middle half▲ 33.3%€43,492within the sector's middle half▼ 14.9%€45,891within the sector's middle half▲ 5.5%€56,399within the sector's middle half▲ 22.9%
Equity€41,364below the sector's middle half-€92,498within the sector's middle half▲ 124%€135,990within the sector's middle half▲ 47.0%€87,255within the sector's middle half▼ 35.8%€97,764within the sector's middle half▲ 12.0%
Total assets€105,956below the sector's middle half-€159,009within the sector's middle half▲ 50.1%€176,554within the sector's middle half▲ 11.0%€107,503below the sector's middle half▼ 39.1%€110,165below the sector's middle half▲ 2.5%
Debt€64,591-€66,512▲ 3.0%€40,564▼ 39.0%€20,248▼ 50.1%€12,402▼ 38.8%
Working capital€27,274-€79,607▲ 192%€124,901▲ 56.9%€75,338▼ 39.7%€95,727▲ 27.1%
Solvency39.0%within the sector's middle half-58.2%within the sector's middle half▲ 19.1pp77.0%within the sector's middle half▲ 18.9pp81.2%within the sector's middle half▲ 4.1pp88.7%above the sector's middle half▲ 7.6pp
above within below the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
€0€20,000€40,000€60,000€80,000Operating result 2021: €53,497€53,497Net result 2021: €38,364€38,364Operating result 2022: €64,754€64,754Net result 2022: €51,133€51,133Operating result 2023: €55,146€55,146Net result 2023: €43,492€43,492Operating result 2024: €58,069€58,069Net result 2024: €45,891€45,891Operating result 2025: €71,308€71,308Net result 2025: €56,399€56,39920212022202320242025€0€20,000€40,000€60,000€80,000Operating result 2023: €55,146€55,100Net result 2023: €43,492€43,500Operating result 2024: €58,069€58,100Net result 2024: €45,891€45,900Operating result 2025: €71,308€71,300Net result 2025: €56,399€56,400202320242025
After the dip in 2023 the operating result has climbed two years in a row; 2025 is 23% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €110,165
Fixed assets €2,037 ▼ 84.0%
Current assets €108,128 ▲ 14.1%
Equity and liabilities €110,165
Equity €97,764 ▲ 12.0%
Debt €12,402 ▼ 38.8%
Debt's share of the balance-sheet total falls from 18.8% to 11.3%. Equity is higher and debt is lower.
Key figures and ratios
2025 value · change against 2024
EBITDA
€82,010▲
2024 · €68,596
Cash flow
€67,101▲
2024 · €56,417
Current ratio
8.72▲
2024 · 4.88
Debt to equity
0.13▼
2024 · 0.23
ROE
57.7%▲
2024 · 52.6%
ROA
51.2%▲
2024 · 42.7%
Interest coverage
352.02▲
2024 · 205.94
Debt ≤ 1 year
€12,402▼
2024 · €19,427
Income taxes
€14,676▲
2024 · €11,845
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 26,964 companies that looked in July 2024 the way this one looks now, 1.5% went bankrupt within 24 months and 95% are still going.

  • Micro
  • 5 to 10 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
1.5% went bankrupt
3.4% stopped otherwise
95% still going

A further 0.3% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a lower bankruptcy probability: 0.1% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,058 companies of July 2024 its group's bankruptcy share. Expected: 1.5%; actually bankrupt within 24 months: 1.6%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.4%
3 0.5% 0.5%
4 0.6% 0.7%
5 0.8% 0.9%
6 1.2% 1.3%
7 1.5% 1.6%
8 1.7% 1.7%
9 2.7% 2.8%
10 5.3% 5.7%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 26,964 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 39 lines
Balance sheet Code20242025
Assets
Total assets20/58€107,503€110,165▲
Fixed assets21/28€12,738€2,037▼
Tangible fixed assets22/27€12,738€2,037▼
Plant, machinery and equipment23€1,469€949▼
Furniture and vehicles24€11,270€1,088▼
Current assets29/58€94,765€108,128▲
Amounts receivable within one year40/41€0-
Other amounts receivable41€0-
Cash at bank and in hand54/58€94,765€108,128▲
Equity and liabilities
Total equity and liabilities10/49€107,503€110,165▲
Equity10/15€87,255€97,764▲
Contributions10/11€3,000€3,000=
Reserves13€84,255€94,764▲
Distributable reserves133€84,255€94,764▲
Amounts payable17/49€20,248€12,402▼
Amounts payable after more than one year17€821-
Financial debts170/4€821-
Amounts payable within one year42/48€19,427€12,402▼
Current portion of amounts payable after more than one year42€9,797€821▼
Trade debts44€529€596▲
Suppliers440/4€529€596▲
Taxes, remuneration and social security45€2,727€4,258▲
Taxes450/3€2,727€4,258▲
Other amounts payable47/48€6,374€6,726▲
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€10,526€10,701▲
Gross operating margin9900€68,596€82,010▲
Operating profit (loss)9901€58,069€71,308▲
Financial charges65/66B€333€233▼
Recurring financial charges65€333€233▼
Profit (loss) for the period before taxes9903€57,736€71,076▲
Income taxes67/77€11,845€14,676▲
Profit (loss) for the period9904€45,891€56,399▲
Profit (loss) for the period to be appropriated9905€45,891€56,399▲
Appropriation of the result
Profit (loss) to be appropriated9906€45,891€56,399▲
Transfer from equity791/2€94,626€45,891▼
Transfer to equity691/2€45,891€56,399▲
To other reserves6921€45,891€56,399▲
Profit to be distributed694/7€94,626€45,891▼
Return on contributions (dividend)694€94,626€45,891▼

The notes to these accounts (4 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20212022202320242025Change
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€10,316€11,576€11,494€10,526€10,701▲ 1.7%
Gross operating margin9900€63,813€76,330€66,640€68,596€82,010▲ 19.6%
Operating profit (loss)9901€53,497€64,754€55,146€58,069€71,308▲ 22.8%
Financial charges65/66B€579€527€428€333€233▼ 30.1%
Recurring financial charges65€579€527€428€333€233▼ 30.1%
Profit (loss) for the period before taxes9903€52,918€64,226€54,718€57,736€71,076▲ 23.1%
Income taxes67/77€14,553€13,093€11,225€11,845€14,676▲ 23.9%
Profit (loss) for the period9904€38,364€51,133€43,492€45,891€56,399▲ 22.9%
Profit (loss) for the period to be appropriated9905€38,364€51,133€43,492€45,891€56,399▲ 22.9%
Line20212022202320242025Change
Assets
Total assets20/58€105,956€159,009€176,554€107,503€110,165▲ 2.5%
Fixed assets21/28€44,777€33,201€21,707€12,738€2,037▼ 84.0%
Tangible fixed assets22/27€44,777€33,201€21,707€12,738€2,037▼ 84.0%
Plant, machinery and equipment23€2,961€1,567€255€1,469€949▼ 35.4%
Furniture and vehicles24€41,816€31,634€21,452€11,270€1,088▼ 90.3%
Current assets29/58€61,179€125,809€154,847€94,765€108,128▲ 14.1%
Amounts receivable within one year40/41--€10,000€0--
Other amounts receivable41--€10,000€0--
Cash at bank and in hand54/58€61,179€125,809€144,847€94,765€108,128▲ 14.1%
Equity and liabilities
Total equity and liabilities10/49€105,956€159,009€176,554€107,503€110,165▲ 2.5%
Equity10/15€41,364€92,498€135,990€87,255€97,764▲ 12.0%
Contributions10/11€3,000€3,000€3,000€3,000€3,000=
Reserves13€38,364€89,498€132,990€84,255€94,764▲ 12.5%
Distributable reserves133€38,364€89,498€132,990€84,255€94,764▲ 12.5%
Amounts payable17/49€64,591€66,512€40,564€20,248€12,402▼ 38.8%
Amounts payable after more than one year17€30,687€20,310€10,618€821--
Financial debts170/4€30,687€20,310€10,618€821--
Amounts payable within one year42/48€33,905€46,202€29,946€19,427€12,402▼ 36.2%
Current portion of amounts payable after more than one year42€8,703€9,590€9,692€9,797€821▼ 91.6%
Trade debts44€9,034--€529€596▲ 12.8%
Suppliers440/4€9,034--€529€596▲ 12.8%
Taxes, remuneration and social security45€14,553€30,445€13,950€2,727€4,258▲ 56.2%
Taxes450/3€14,553€30,445€13,950€2,727€4,258▲ 56.2%
Other amounts payable47/48€1,615€6,166€6,304€6,374€6,726▲ 5.5%
Line20212022202320242025Change
Profit (loss) for the period9904€38,364€51,133€43,492€45,891€56,399▲ 22.9%
+ Depreciation and write-downs630€10,316€11,576€11,494€10,526€10,701▲ 1.7%
Operating cash flow (approximation)€48,681€62,710€54,986€56,417€67,101▲ 18.9%
Investment in fixed assets (approximation)-€0€0-€1,558€0▲ 100%
Change in cash-€64,630€19,038-€50,082€13,363▲ 127%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
21-05
NBB filing Annual accounts filed
fiscal year 2025 · micro schema
2025
31-12
Financial Highest result since 2021net €56,399 ▲22.9%
Operating result €71,308, net result €56,399, both a record.
22-05
NBB filing Annual accounts filed
fiscal year 2024 · micro schema
2024
24-06
NBB filing Annual accounts filed
fiscal year 2023 · micro schema
2023
31-12
Financial Equity above €100,000Eq €135,990 ▲47%
3 profitable years in a row build equity to €135,990.
25-04
NBB filing Annual accounts filed
fiscal year 2022 · micro schema
2022
29-06
NBB filing Annual accounts filed
fiscal year 2021 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 1 act read
About the unread acts

We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Tienen · 1 establishment unit since 2020
seat establishment The establishment unit on the map
Ground area
687 m²
Building footprint
181 m²
Volume, LiDAR
156 m³
Parcel 24113C0470/00B000, Flanders · tallest building 5.0 m. Linked by address, not a title deed.
1 establishment unit
Uvea
Denneboomweg(VSN) 1, 3300 TienenSpecialist medical practice
since 20202.305.817.583
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
24113C0470/00B000 Flanders 687 m² 1 · 181 m² 5.0 m
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Similar companies · same sector, comparable size

Of 16,631 companies in sector 86220 we hold annual accounts for 7,983. 6,270 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Identification & contact

Identification
Legal formPrivate limited company
Founded29-07-2020
Fiscal year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
86995Nutrition and dietetics services
E-invoicing
Reachable via Peppol
Peppol ID 0208:0751577675
Also 9925:BE0751577675
Registered 08-12-2025

Register as of 27 September 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.